PL370738A1 - Imidazopirydyny podstawione mocznikiem - Google Patents

Imidazopirydyny podstawione mocznikiem

Info

Publication number: PL370738A1
Authority: PL; Poland
Prior art keywords: urea substituted; substituted imidazopyridines; imidazopyridines; urea; substituted
Prior art date: 2001-12-06

Application number

PL02370738A

Other languages

English (en)

Inventor

Joseph F. Dellaria

Chad A. Haraldson

Philip D. Heppner

Kyle J. Lindstrom

Bryon A. Merrill

Original Assignee

3M Innovative Properties Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-06

Filing date

2002-06-07

Publication date

2005-05-30

2002-06-07 Application filed by 3M Innovative Properties Company filed Critical 3M Innovative Properties Company

2005-05-30 Publication of PL370738A1 publication Critical patent/PL370738A1/pl

Links

239000004202 carbamide Substances 0.000 title 1
150000005232 imidazopyridines Chemical class 0.000 title 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
AIDS & HIV (AREA)
Biotechnology (AREA)
Ophthalmology & Optometry (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL02370738A 2001-12-06 2002-06-07 Imidazopirydyny podstawione mocznikiem PL370738A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10/016,073 US20020107262A1 (en)	2000-12-08	2001-12-06	Substituted imidazopyridines

Publications (1)

Publication Number	Publication Date
PL370738A1 true PL370738A1 (pl)	2005-05-30

Family

ID=21775232

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PL02370738A PL370738A1 (pl)	2001-12-06	2002-06-07	Imidazopirydyny podstawione mocznikiem
PL02374260A PL374260A1 (pl)	2001-12-06	2002-06-07	Imidazopirydyny podstawione sulfonamidem
PL02370702A PL370702A1 (pl)	2001-12-06	2002-06-07	Imidazopirydyny podstawione amidem

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
PL02374260A PL374260A1 (pl)	2001-12-06	2002-06-07	Imidazopirydyny podstawione sulfonamidem
PL02370702A PL370702A1 (pl)	2001-12-06	2002-06-07	Imidazopirydyny podstawione amidem

Country Status (18)

Country	Link
US (1)	US20020107262A1 (pl)
EP (3)	EP1451187A1 (pl)
JP (3)	JP2005513052A (pl)
KR (3)	KR20040105695A (pl)
CN (4)	CN100372846C (pl)
AU (3)	AU2002315006B2 (pl)
BR (3)	BR0214752A (pl)
CA (3)	CA2468659A1 (pl)
HR (3)	HRP20040504A2 (pl)
IL (3)	IL161946A0 (pl)
MX (3)	MXPA04005363A (pl)
NO (3)	NO20042621L (pl)
NZ (3)	NZ532926A (pl)
PL (3)	PL370738A1 (pl)
RU (3)	RU2004117156A (pl)
UA (3)	UA77710C2 (pl)
WO (3)	WO2003050119A2 (pl)
ZA (3)	ZA200405337B (pl)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005538057A (ja)	2002-06-07	2005-12-15	スリーエムイノベイティブプロパティズカンパニー	エーテル置換イミダゾピリジン
MXPA05007485A (es)	2003-01-14	2006-01-30	Arena Pharm Inc	Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
US20040265351A1 (en)	2003-04-10	2004-12-30	Miller Richard L.	Methods and compositions for enhancing immune response
EP1615665A4 (en) *	2003-04-10	2010-10-06	3M Innovative Properties Co	DISTRIBUTION OF THE IMMUNE RESPONSE MODIFYING LINKS
AR045047A1 (es)	2003-07-11	2005-10-12	Arena Pharm Inc	Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
BRPI0413558A (pt)	2003-08-12	2006-10-17	3M Innovative Properties Co	compostos contendo imidazo substituìdo por hidroxilamina
US7799800B2 (en) *	2003-08-14	2010-09-21	3M Innovative Properties Company	Lipid-modified immune response modifiers
AU2004268625B2 (en)	2003-08-27	2011-03-31	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted imidazoquinolines
AU2004270201A1 (en)	2003-09-05	2005-03-17	3M Innovative Properties Company	Treatment for CD5+ B cell lymphoma
KR20060120069A (ko)	2003-10-03	2006-11-24	쓰리엠 이노베이티브 프로퍼티즈 컴파니	피라졸로피리딘 및 그의 유사체
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
AR046046A1 (es)	2003-10-03	2005-11-23	3M Innovative Properties Co	Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
JP2007509057A (ja) *	2003-10-15	2007-04-12	カイロンコーポレイション	ウイルス阻害のための組成物および方法
EP1685129A4 (en) *	2003-11-14	2008-10-22	3M Innovative Properties Co	OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
CA2545825A1 (en)	2003-11-14	2005-06-02	3M Innovative Properties Company	Hydroxylamine substituted imidazo ring compounds
CA2547020C (en)	2003-11-25	2014-03-25	3M Innovative Properties Company	1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
EP1686992A4 (en) *	2003-11-25	2009-11-04	3M Innovative Properties Co	HYDROXYLAMINE, AND IMIDAZOQUINOLEINS, AND IMIDAZOPYRIDINES AND IMIDAZONAPHTYRIDINE SUBSTITUTED WITH OXIME
JP2007513170A (ja) *	2003-12-04	2007-05-24	スリーエムイノベイティブプロパティズカンパニー	スルホン置換イミダゾ環エーテル
JP2007530450A (ja) *	2003-12-29	2007-11-01	スリーエムイノベイティブプロパティズカンパニー	ピペラジン、［１，４］ジアゼパン、［１，４］ジアゾカン、および［１，５］ジアゾカン縮合イミダゾ環化合物
JP2007517035A (ja)	2003-12-29	2007-06-28	スリーエムイノベイティブプロパティズカンパニー	アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (en)	2003-12-30	2006-09-13	3M Innovative Properties Company	Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
WO2005094531A2 (en)	2004-03-24	2005-10-13	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123079A2 (en) *	2004-06-14	2005-12-29	3M Innovative Properties Company	Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en)	2004-06-15	2011-09-13	3M Innovative Properties Company	Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (en)	2004-06-18	2006-06-22	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US8541438B2 (en)	2004-06-18	2013-09-24	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
WO2006038923A2 (en)	2004-06-18	2006-04-13	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
US8026366B2 (en)	2004-06-18	2011-09-27	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7884207B2 (en) *	2004-06-18	2011-02-08	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
EP1789042B1 (en) *	2004-09-02	2012-05-02	3M Innovative Properties Company	1-alkoxy 1h-imidazo ring systems and methods
WO2006029115A2 (en)	2004-09-02	2006-03-16	3M Innovative Properties Company	2-amino 1h imidazo ring systems and methods
EP1804583A4 (en) *	2004-10-08	2009-05-20	3M Innovative Properties Co	ADJUVANT FOR DNA VACCINE
PL1830876T3 (pl) *	2004-12-30	2015-09-30	Meda Ab	Zastosowanie imikwimodu do leczenia przerzutów do skóry wywodzących się od guza stanowiącego raka piersi
JP5543068B2 (ja)	2004-12-30	2014-07-09	スリーエムイノベイティブプロパティズカンパニー	キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
US8436176B2 (en) *	2004-12-30	2013-05-07	Medicis Pharmaceutical Corporation	Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
EP1831221B1 (en)	2004-12-30	2012-08-08	3M Innovative Properties Company	Substituted chiral fused 1,2 imidazo 4,5-c ring compounds
CA2592897A1 (en) *	2004-12-30	2006-07-13	Takeda Pharmaceutical Company Limited	1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate
AU2006210392A1 (en)	2005-02-04	2006-08-10	Coley Pharmaceutical Group, Inc.	Aqueous gel formulations containing immune response modifiers
AU2006212765B2 (en)	2005-02-09	2012-02-02	3M Innovative Properties Company	Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
US8378102B2 (en)	2005-02-09	2013-02-19	3M Innovative Properties Company	Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods
EP1845988A2 (en)	2005-02-11	2007-10-24	3M Innovative Properties Company	Substituted imidazoquinolines and imidazonaphthyridines
AU2006213746A1 (en)	2005-02-11	2006-08-17	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
EP1851224A2 (en)	2005-02-23	2007-11-07	3M Innovative Properties Company	Hydroxyalkyl substituted imidazoquinolines
AU2006216686A1 (en)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Method of preferentially inducing the biosynthesis of interferon
EP1851220A2 (en)	2005-02-23	2007-11-07	3M Innovative Properties Company	Hydroxyalkyl substituted imidazonaphthyridines
JP2008531567A (ja)	2005-02-23	2008-08-14	コーリーファーマシューティカルグループ，インコーポレイテッド	ヒドロキシアルキル置換イミダゾキノリン化合物および方法
EP1869043A2 (en)	2005-04-01	2007-12-26	Coley Pharmaceutical Group, Inc.	Pyrazolopyridine-1,4-diamines and analogs thereof
AU2006232375A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
CA2605808A1 (en) *	2005-04-25	2006-11-02	3M Innovative Properties Company	Immunostimulatory compositions
ZA200803029B (en)	2005-09-09	2009-02-25	Coley Pharm Group Inc	Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
EA200800782A1 (ru)	2005-09-09	2008-08-29	Коли Фармасьютикал Груп, Инк.	ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ
CN100344325C (zh) *	2005-10-17	2007-10-24	华南师范大学	一种治疗宫颈癌的药物及其制备方法与应用
KR20080083270A (ko)	2005-11-04	2008-09-17	콜레이 파마시티컬 그룹, 인코포레이티드	하이드록시 및 알콕시 치환된 1에이치 이미다조퀴놀린 및방법
EP1988896A4 (en)	2006-02-22	2011-07-27	3M Innovative Properties Co	CONJUGATES TO MODIFY IMMUNE REACTIONS
US8329721B2 (en)	2006-03-15	2012-12-11	3M Innovative Properties Company	Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods
US7906506B2 (en)	2006-07-12	2011-03-15	3M Innovative Properties Company	Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
AU2007288124B2 (en) *	2006-08-24	2013-04-04	Australian Nuclear Science & Technology Organisation	Fluorinated ligands for targeting peripheral benzodiazepine receptors
US8178539B2 (en)	2006-09-06	2012-05-15	3M Innovative Properties Company	Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
GB0625827D0 (en) *	2006-12-22	2007-02-07	Astex Therapeutics Ltd	New compounds
US20080149123A1 (en)	2006-12-22	2008-06-26	Mckay William D	Particulate material dispensing hairbrush with combination bristles
HRP20150642T1 (hr)	2006-12-22	2015-08-14	Astex Therapeutics Limited	BICIKLIÄŚKE HETEROCIKLIÄŚKE TVARI KAO INHIBITORI FGFR-a
US8513276B2 (en)	2006-12-22	2013-08-20	Astex Therapeutics Limited	Imidazo[1,2-a]pyridine compounds for use in treating cancer
GB0720041D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New Compounds
GB0720038D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New compounds
CN101239978A (zh) *	2008-03-05	2008-08-13	南方医科大学	一种咪唑并吡啶类化合物
GB0810902D0 (en)	2008-06-13	2008-07-23	Astex Therapeutics Ltd	New compounds
GB0906472D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
GB0906470D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
EP2516387B1 (en) *	2009-12-21	2018-02-21	Institut National de la Sante et de la Recherche Medicale (INSERM)	Inhibitors of cyclophilins for use in the prevention and/or the treatment of viral pathologies or infections
US9242980B2 (en)	2010-08-17	2016-01-26	3M Innovative Properties Company	Lipidated immune response modifier compound compositions, formulations, and methods
EP3323818A1 (en)	2010-09-22	2018-05-23	Arena Pharmaceuticals, Inc.	Modulators of the gpr119 receptor and the treatment of disorders related thereto
JP6460789B2 (ja)	2011-06-03	2019-01-30	スリーエムイノベイティブプロパティズカンパニー	ポリエチレングリコールセグメントを有するヘテロ２官能性リンカー及び該リンカーから調製された免疫反応調節複合体
BR112013031039B1 (pt)	2011-06-03	2020-04-28	3M Innovative Properties Co	compostos de hidrazino 1h-imidazoquinolina-4-aminas, conjugados feitos destes compostos, composição e composição farmacêutica compreendendo ditos compostos e conjugados, usos dos mesmos e método de fabricação do conjugado
US10471139B2 (en) *	2013-08-15	2019-11-12	The University Of Kansas	Toll-like receptor agonists
PL3242666T3 (pl)	2015-01-06	2025-02-17	Arena Pharmaceuticals, Inc.	Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
BR112017027656B1 (pt)	2015-06-22	2023-12-05	Arena Pharmaceuticals, Inc.	Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
WO2018107173A1 (en) *	2016-12-09	2018-06-14	Vanderbilt University	Glutamine transport inhibitors and methods for treating cancer
MX2019009841A (es)	2017-02-16	2020-01-30	Arena Pharm Inc	Compuestos y metodos para el tratamiento de la colangitis biliar primaria.
WO2019123178A1 (en)	2017-12-20	2019-06-27	3M Innovative Properties Company	Amide substitued imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier
CA3102136A1 (en)	2018-06-06	2019-12-12	Arena Pharmaceuticals, Inc.	Methods of treating conditions related to the s1p1 receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH09500128A (ja) *	1993-07-15	1997-01-07	ミネソタマイニングアンドマニュファクチャリングカンパニー	イミダゾ〔４，５−ｃ〕ピリジン−４−アミン
IL129319A0 (en) *	1996-10-25	2000-02-17	Minnesota Mining & Mfg	Immune response modifier compounds for treatment of TH2 mediated and related diseases
US6331539B1 (en) *	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6451810B1 (en) *	1999-06-10	2002-09-17	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6541485B1 (en) *	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6376669B1 (en) *	1999-11-05	2002-04-23	3M Innovative Properties Company	Dye labeled imidazoquinoline compounds
UA74593C2 (en) *	2000-12-08	2006-01-16	3M Innovative Properties Co	Substituted imidazopyridines

2001
- 2001-12-06 US US10/016,073 patent/US20020107262A1/en not_active Abandoned
2002
- 2002-06-07 AU AU2002315006A patent/AU2002315006B2/en not_active Expired - Fee Related
- 2002-06-07 NZ NZ532926A patent/NZ532926A/en unknown
- 2002-06-07 NZ NZ532927A patent/NZ532927A/en unknown
- 2002-06-07 CA CA002468659A patent/CA2468659A1/en not_active Abandoned
- 2002-06-07 MX MXPA04005363A patent/MXPA04005363A/es unknown
- 2002-06-07 PL PL02370738A patent/PL370738A1/pl not_active Application Discontinuation
- 2002-06-07 EP EP02744260A patent/EP1451187A1/en not_active Withdrawn
- 2002-06-07 CA CA002468174A patent/CA2468174A1/en not_active Abandoned
- 2002-06-07 BR BR0214752-1A patent/BR0214752A/pt not_active IP Right Cessation
- 2002-06-07 NZ NZ532770A patent/NZ532770A/en unknown
- 2002-06-07 MX MXPA04005412A patent/MXPA04005412A/es not_active Application Discontinuation
- 2002-06-07 CN CNB028242866A patent/CN100372846C/zh not_active Expired - Fee Related
- 2002-06-07 CN CNA2008100030374A patent/CN101220028A/zh active Pending
- 2002-06-07 JP JP2003551141A patent/JP2005513052A/ja active Pending
- 2002-06-07 CN CNB028242858A patent/CN100402528C/zh not_active Expired - Fee Related
- 2002-06-07 RU RU2004117156/04A patent/RU2004117156A/ru not_active Application Discontinuation
- 2002-06-07 IL IL16194602A patent/IL161946A0/xx unknown
- 2002-06-07 RU RU2004117159/04A patent/RU2004117159A/ru not_active Application Discontinuation
- 2002-06-07 PL PL02374260A patent/PL374260A1/pl not_active Application Discontinuation
- 2002-06-07 AU AU2002312414A patent/AU2002312414B2/en not_active Expired - Fee Related
- 2002-06-07 KR KR10-2004-7008676A patent/KR20040105695A/ko not_active Ceased
- 2002-06-07 HR HRP20040504 patent/HRP20040504A2/hr not_active Application Discontinuation
- 2002-06-07 HR HRP20040503 patent/HRP20040503A2/hr not_active Application Discontinuation
- 2002-06-07 JP JP2003551142A patent/JP2005511745A/ja active Pending
- 2002-06-07 JP JP2003551143A patent/JP2005511746A/ja active Pending
- 2002-06-07 WO PCT/US2002/018284 patent/WO2003050119A2/en not_active Ceased
- 2002-06-07 HR HRP20040506 patent/HRP20040506A2/hr not_active Application Discontinuation
- 2002-06-07 BR BR0214999-0A patent/BR0214999A/pt not_active IP Right Cessation
- 2002-06-07 IL IL16194502A patent/IL161945A0/xx unknown
- 2002-06-07 CA CA002468164A patent/CA2468164A1/en not_active Abandoned
- 2002-06-07 PL PL02370702A patent/PL370702A1/pl not_active Application Discontinuation
- 2002-06-07 WO PCT/US2002/018282 patent/WO2003050118A1/en not_active Ceased
- 2002-06-07 EP EP02741939A patent/EP1451186A2/en not_active Withdrawn
- 2002-06-07 KR KR10-2004-7008686A patent/KR20040105696A/ko not_active Ceased
- 2002-06-07 EP EP02739783A patent/EP1453829A1/en not_active Withdrawn
- 2002-06-07 AU AU2002345615A patent/AU2002345615B2/en not_active Expired - Fee Related
- 2002-06-07 CN CNB028242874A patent/CN100387597C/zh not_active Expired - Fee Related
- 2002-06-07 BR BR0214749-1A patent/BR0214749A/pt not_active IP Right Cessation
- 2002-06-07 WO PCT/US2002/018220 patent/WO2003050117A1/en not_active Ceased
- 2002-06-07 MX MXPA04005331A patent/MXPA04005331A/es unknown
- 2002-06-07 RU RU2004117161/04A patent/RU2004117161A/ru not_active Application Discontinuation
- 2002-06-07 IL IL16178702A patent/IL161787A0/xx unknown
- 2002-06-07 KR KR10-2004-7008644A patent/KR20040105694A/ko not_active Ceased
- 2002-07-06 UA UA20040604342A patent/UA77710C2/uk unknown
- 2002-07-06 UA UA20040604339A patent/UA77709C2/uk unknown
- 2002-07-06 UA UA20040604343A patent/UA77711C2/uk unknown
2004
- 2004-06-22 NO NO20042621A patent/NO20042621L/no not_active Application Discontinuation
- 2004-06-24 NO NO20042661A patent/NO20042661L/no not_active Application Discontinuation
- 2004-06-29 NO NO20042755A patent/NO20042755L/no not_active Application Discontinuation
- 2004-07-05 ZA ZA200405337A patent/ZA200405337B/en unknown
- 2004-07-05 ZA ZA200405336A patent/ZA200405336B/en unknown
- 2004-07-05 ZA ZA200405334A patent/ZA200405334B/en unknown

Also Published As

Publication number	Publication date
CA2468164A1 (en)	2003-06-19
HRP20040504A2 (en)	2004-12-31
ZA200405337B (en)	2006-12-27
UA77711C2 (en)	2007-01-15
US20020107262A1 (en)	2002-08-08
AU2002312414A1 (en)	2003-06-23
IL161945A0 (en)	2005-11-20
KR20040105694A (ko)	2004-12-16
WO2003050118A1 (en)	2003-06-19
CN100402528C (zh)	2008-07-16
CA2468174A1 (en)	2003-06-19
NO20042621L (no)	2004-06-22
NZ532770A (en)	2006-07-28
AU2002312414B2 (en)	2009-02-19
MXPA04005363A (es)	2004-09-27
EP1451186A2 (en)	2004-09-01
BR0214752A (pt)	2005-08-02
RU2004117159A (ru)	2006-01-10
NZ532927A (en)	2006-06-30
BR0214999A (pt)	2004-12-28
NO20042755L (no)	2004-06-29
IL161787A0 (en)	2005-11-20
AU2002345615A1 (en)	2003-06-23
CN100372846C (zh)	2008-03-05
WO2003050119A3 (en)	2003-07-10
CN100387597C (zh)	2008-05-14
CN101220028A (zh)	2008-07-16
ZA200405334B (en)	2006-12-27
JP2005511745A (ja)	2005-04-28
EP1451187A1 (en)	2004-09-01
AU2002345615B2 (en)	2009-01-15
HRP20040506A2 (en)	2004-12-31
JP2005511746A (ja)	2005-04-28
WO2003050119A2 (en)	2003-06-19
PL370702A1 (pl)	2005-05-30
EP1453829A1 (en)	2004-09-08
MXPA04005331A (es)	2004-09-13
NO20042661L (no)	2004-06-24
HRP20040503A2 (en)	2004-12-31
RU2004117156A (ru)	2006-01-10
ZA200405336B (en)	2006-12-27
WO2003050117A1 (en)	2003-06-19
RU2004117161A (ru)	2005-05-10
UA77709C2 (en)	2007-01-15
CN1599738A (zh)	2005-03-23
JP2005513052A (ja)	2005-05-12
MXPA04005412A (es)	2004-10-11
AU2002315006B2 (en)	2009-01-29
NZ532926A (en)	2006-06-30
KR20040105695A (ko)	2004-12-16
CN1599740A (zh)	2005-03-23
CA2468659A1 (en)	2003-06-19
UA77710C2 (en)	2007-01-15
KR20040105696A (ko)	2004-12-16
IL161946A0 (en)	2005-11-20
PL374260A1 (pl)	2005-10-03
AU2002315006A1 (en)	2003-06-23
BR0214749A (pt)	2004-08-31
CN1599739A (zh)	2005-03-23

Legal Events

Date	Code	Title	Description
2010-03-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL161946A0 (en)	2005-11-20	Urea substituted imidazopyridines
IL159445A0 (en)	2004-06-01	Azaindoles
AU2002358700A8 (en)	2003-07-15	Urea derivatives as vr1- antagonists
AU3954702A (en)	2002-06-18	Substituted imidazopyridines
SI1671949T1 (sl)	2008-10-31	Substituirani pridinilamini
ZA200309522B (en)	2005-02-23	Substituted cyclohexane-1-4diamine derivatives
IL160701A0 (en)	2004-08-31	3-substituted-4-pyrimidone derivatives
GB0130669D0 (en)	2002-02-06	Structural component
HUP0303449A3 (en)	2005-02-28	Substituted benzofuran-2-carboxamides derivatives
PL362643A1 (pl)	2004-11-02	Podstawione fluoroalkoksyfenylosulfonylomoczniki
GB0102146D0 (en)	2001-03-14	Attachment means
HUP0401949A3 (en)	2009-07-28	4-imidazolin-2-one derivatives
HUP0303186A3 (en)	2007-06-28	4-aminobenzopyran derivatives
HUP0500026A3 (en)	2008-02-28	N-heteroarylnicotinamide derivatives
PL368050A1 (pl)	2005-03-21	Podstawione 4-aminocykloheksanole
EP1364954A4 (en)	2009-10-28	Dicarba closo DODECARBORANDERIVATE
PL364601A1 (pl)	2004-12-13	Podstawione związki benzoheterocykliczne zawierające azot
EG23586A (en)	2006-09-13	Haemagel solution
CA92739S (en)	2001-06-29	Stopwatch
CA92741S (en)	2001-06-29	Stopwatch
CA92744S (en)	2001-06-29	Stopwatch
CA92743S (en)	2001-06-26	Stopwatch
CA92742S (en)	2001-06-29	Stopwatch
CA92631S (en)	2001-06-15	Stopwatch
CA92738S (en)	2001-06-29	Stopwatch